Endurance and resistance training affect high fat diet-induced increase of ceramides, inflammasome expression, and systemic inflammation in mice

Journal of Diabetes Research

Volumn 2016, Issue , 2016, Pages

  Mardare, Cornelia ^a   Krüger, Karsten ^a   Liebisch, Gerhard ^b   Seimetz, Michael ^a   Couturier, Aline ^a   Ringseis, Robert ^a   Wilhelm, Jochen ^a   Weissmann, Norbert ^a   Eder, Klaus ^a   Mooren, Frank Christoph ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; CERAMIDE; CHEMOKINE; CRYOPYRIN; FATTY ACID; INFLAMMASOME; INTERLEUKIN 18; MACROPHAGE INFLAMMATORY PROTEIN 1GAMMA; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; AUTACOID; CARRIER PROTEIN; CERS4 PROTEIN, MOUSE; CYTOKINE; GLUCOSE BLOOD LEVEL; NLRP3 PROTEIN, MOUSE; SERINE PALMITOYLTRANSFERASE; SPHINGOSINE ACYLTRANSFERASE; SPTLC2 PROTEIN, MOUSE;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; ENDURANCE TRAINING; FATTY ACID BLOOD LEVEL; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE; INFLAMMATION; LIPID BLOOD LEVEL; LIPID DIET; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESISTANCE TRAINING; SERUM; WEIGHT REDUCTION; ANIMAL; BLOOD; C57BL MOUSE; DISEASE MODEL; ENDURANCE; GLUCOSE BLOOD LEVEL; IMMUNOLOGY; LIVER; METABOLISM; OBESITY; PATHOPHYSIOLOGY;

ADIPOSE TISSUE; ANIMALS; BLOOD GLUCOSE; CARRIER PROTEINS; CERAMIDES; CYTOKINES; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; GLUCOSE INTOLERANCE; INFLAMMASOMES; INFLAMMATION; INFLAMMATION MEDIATORS; LIVER; MALE; MICE, INBRED C57BL; NLR FAMILY, PYRIN DOMAIN-CONTAINING 3 PROTEIN; OBESITY; PHYSICAL ENDURANCE; RESISTANCE TRAINING; SERINE C-PALMITOYLTRANSFERASE; SPHINGOSINE N-ACYLTRANSFERASE; WEIGHT LOSS;

EID: 84953889295     PISSN: 23146745     EISSN: 23146753     Source Type: Journal    
DOI: 10.1155/2016/4536470     Document Type: Article

References (50)

1. F. P. de Heredia, S. Gomez-Martinez, and A. Marcos, "Obesity, inflammation and the immune system," The Proceedings of the Nutrition Society, vol. 71, no. 2, pp. 332-338, 2012.
2. A. R. Johnson, J. Justin Milner, and L. Makowski, "The inflammation highway: metabolism accelerates inflammatory traffic in obesity," Immunological Reviews, vol. 249, no. 1, pp. 218-238, 2012.
3. R. Ross, I. Janssen, J. Dawson et al., "Exercise-induced reduction in obesity and insulin resistance in women: a randomized controlled trial," Obesity Research, vol. 12, no. 5, pp. 789-798, 2004.
4. Y. Hamada, H. Nagasaki, A. Fujiya et al., "Involvement of de novo ceramide synthesis in pro-inflammatory adipokine secretion and adipocyte-macrophage interaction," The Journal of Nutritional Biochemistry, vol. 25, no. 12, pp. 1309-1316, 2014.
5. W. L. Holland, J. T. Brozinick, L.-P. Wang et al., "Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance," CellMetabolism, vol. 5, no. 3, pp. 167-179, 2007.
6. J. L. Durstine, P. W. Grandjean, P. G. Davis, M. A. Ferguson, N. L. Alderson, and K. D. DuBose, "Blood lipid and lipoprotein adaptations to exercise: a quantitative analysis," SportsMedicine, vol. 31, no. 15, pp. 1033-1062, 2001.
7. G. A. Kelley, K. S. Kelley, S. Roberts, and W. Haskell, "Comparison of aerobic exercise, diet or both on lipids and lipoproteins in adults: a meta-analysis of randomized controlled trials," Clinical Nutrition, vol. 31, no. 2, pp. 156-167, 2012.
8. N. Goto-Inoue, K. Yamada, A. Inagaki et al., "Lipidomics analysis revealed the phospholipid compositional changes in muscle by chronic exercise and high-fat diet," Scientific Reports, vol. 3, article 3267, 2013.
9. A. G. Oliveira, B. M. Carvalho, N. Tobar et al., "Physical exercise reduces circulating lipopolysaccharide and TLR4 activation and improves insulin signaling in tissues of DIO rats," Diabetes, vol. 60, no. 3, pp. 784-796, 2011.
10. N. Kawanishi, H. Yano, Y. Yokogawa, and K. Suzuki, "Exercise training inhibits inflammation in adipose tissue via both suppression of macrophage infiltration and acceleration of phenotypic switching fromM1 toM2 macrophages in high-fatdiet-induced obese mice," Exercise Immunology Review, vol. 16, pp. 105-118, 2010.
11. M. C. Venables and A. E. Jeukendrup, "Endurance training and obesity: effect on substrate metabolism and insulin sensitivity," Medicine and Science in Sports and Exercise, vol. 40, no. 3, pp. 495-502, 2008.
12. S. M. Abd El-Kader, "Aerobic versus resistance exercise training in modulation of insulin resistance, adipocytokines and inflammatory cytokine levels in obese type 2 diabetic patients," Journal of Advanced Research, vol. 2, no. 2, pp. 179-183, 2011.
13. C. Castaneda, J. E. Layne, L. Munoz-Orians et al., "A randomized controlled trial of resistance exercise training to improve glycemic control in older adults with type 2 diabetes," Diabetes Care, vol. 25, no. 12, pp. 2335-2341, 2002.
14. A. Honkola, T. Forsen, and J. Eriksson, "Resistance training improves the metabolic profile in individuals with type 2 diabetes," Acta Diabetologica, vol. 34, no. 4, pp. 245-248, 1997.
15. M. L. M. P. Jorge, V. N. de Oliveira, N. M. Resende et al., "The effects of aerobic, resistance, and combined exercise on metabolic control, inflammatory markers, adipocytokines, and muscle insulin signaling in patients with type 2 diabetes mellitus," Metabolism: Clinical and Experimental, vol. 60, no. 9, pp. 1244-1252, 2011.
16. B. Strasser and W. Schobersberger, "Evidence for resistance training as a treatment therapy in obesity," Journal of Obesity, vol. 2011, Article ID 482564, 9 pages, 2011.
17. M. Gleeson, N. C. Bishop, D. J. Stensel, M. R. Lindley, S. S. Mastana, and M. A. Nimmo, "The anti-inflammatory effects of exercise: mechanisms and implications for the prevention and treatment of disease," Nature Reviews Immunology, vol. 11, no. 9, pp. 607-610, 2011.
18. B. Vandanmagsar, Y.-H. Youm, A. Ravussin et al., "The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance," Nature Medicine, vol. 17, no. 2, pp. 179-189, 2011.
19. J. J. Dube, F. Amati, F. G. S. Toledo et al., "Effects of weight loss and exercise on insulin resistance, and intramyocellular triacylglycerol, diacylglycerol and ceramide," Diabetologia, vol. 54, no. 5, pp. 1147-1156, 2011.
20. M. Levy and A. H. Futerman, "Mammalian ceramide synthases," IUBMB Life, vol. 62, no. 5, pp. 347-356, 2010.
21. C. M. Taniguchi, B. Emanuelli, and C. R. Kahn, "Critical nodes in signalling pathways: insights into insulin action," Nature Reviews Molecular Cell Biology, vol. 7, no. 2, pp. 85-96, 2006.
22. A. Bachnio-Zabielska, P. Zabielski, M. Baranowski, and J. Gorski, "Aerobic training in rats increases skeletal muscle sphingomyelinase and serine palmitoyltransferase activity, while decreasing ceramidase activity," Lipids, vol. 46, no. 3, pp. 229-238, 2011.
23. C. Handschin and B. M. Spiegelman, "The role of exercise and PGC1α in inflammation and chronic disease," Nature, vol. 454, no. 7203, pp. 463-469, 2008.
24. J. A. Hawley, M. Hargreaves, M. J. Joyner, and J. R. Zierath, "Integrative biology of exercise," Cell, vol. 159, no. 4, pp. 738-749, 2014.
25. K. Kruger, A. Lechtermann, M. Fobker, K. Volker, and F. C. Mooren, "Exercise-induced redistribution of T lymphocytes is regulated by adrenergic mechanisms," Brain, Behavior, and Immunity, vol. 22, no. 3, pp. 324-338, 2008.
26. K. Kruger, D. K. Gessner, M. Seimetz et al., "Functional and muscular adaptations in an experimental model for isometric strength training in mice," PLoS ONE, vol. 8, no. 11, Article ID e79069, 2013.
27. R. L. Bradley, J. Y. Jeon, F.-F. Liu, and E. Maratos-Flier, "Voluntary exercise improves insulin sensitivity and adipose tissue inflammation in diet-induced obese mice," The American Journal of Physiology-Endocrinology andMetabolism, vol. 295, no. 3, pp. E586-E594, 2008.
28. J. Keller, R. Ringseis, A. Koc, I. Lukas, H. Kluge, and K. Eder, "Supplementation with L-carnitine downregulates genes of the ubiquitin proteasome system in the skeletal muscle and liver of piglets," Animal, vol. 6, no. 1, pp. 70-78, 2012.
29. J. Vandesompele, K. De Preter, F. Pattyn et al., "Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes," Genome Biology, vol. 3, no. 7, pp. 1-11, 2002.
30. G. Liebisch, B. Lieser, J. Rathenberg, W. Drobnik, and G. Schmitz, "High-throughput quantification of phosphatidylcholine and sphingomyelin by electrospray ionization tandem mass spectrometry coupled with isotope correction algorithm," Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids, vol. 1686, no. 1-2, pp. 108-117, 2004.
31. E. G. Bligh and W. J. Dyer, "A rapid method of total lipid extraction and purification," Canadian Journal of Biochemistry and Physiology, vol. 37, no. 8, pp. 911-917, 1959.
32. G. Liebisch, W. Drobnik, M. Reil et al., "Quantitativemeasurement of different ceramide species from crude cellular extracts by electrospray ionization tandem mass spectrometry (ESIMS/ MS)," Journal of LipidResearch, vol. 40, no. 8, pp. 1539-1546, 1999.
33. J. Ecker, M. Scherer, G. Schmitz, and G. Liebisch, "A rapid GC-MS method for quantification of positional and geometric isomers of fatty acid methyl esters," Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, vol. 897, pp. 98-104, 2012.
34. V. J. Vieira, R. J. Valentine, K. R. Wilund, N. Antao, T. Baynard, and J. A. Woods, "Effects of exercise and low-fat diet on adipose tissue inflammation and metabolic complications in obese mice," American Journal of Physiology-Endocrinology and Metabolism, vol. 296, no. 5, pp. E1164-E1171, 2009.
35. J. Boon, A. J. Hoy, R. Stark et al., "Ceramides contained in LDL are elevated in type 2 diabetes and promote inflammation and skeletal muscle insulin resistance," Diabetes, vol. 62, no. 2, pp. 401-410, 2013.
36. S. Stratford, K. L. Hoehn, F. Liu, and S. A. Summers, "Regulation of insulin action by ceramide: dual mechanisms linking ceramide accumulation to the inhibition of Akt/protein kinase B," Journal of Biological Chemistry, vol. 279, no. 35, pp. 36608-36615, 2004.
37. N. Kawanishi, H. Niihara, T. Mizokami, H. Yano, and K. Suzuki, "Exercise training attenuates adipose tissue fibrosis in dietinduced obese mice," Biochemical and Biophysical Research Communications, vol. 440, no. 4, pp. 774-779, 2013.
38. H. Wen, D. Gris, Y. Lei et al., "Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling," Nature Immunology, vol. 12, no. 5, pp. 408-415, 2011.
39. J. A. Chavez and S. A. Summers, "A ceramide-centric view of insulin resistance," Cell Metabolism, vol. 15, no. 5, pp. 585-594, 2012.
40. J. M. Haus, S. R. Kashyap, T. Kasumov et al., "Plasma ceramides are elevated in obese subjects with type 2 diabetes and correlate with the severity of insulin resistance," Diabetes, vol. 58, no. 2, pp. 337-343, 2009.
41. Y. Ohno, S. Suto, M. Yamanaka et al., "ELOVL1 production of C24 acyl-CoAs is linked to C24 sphingolipid synthesis," Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 43, pp. 18439-18444, 2010.
42. P. J. Larsen and N. Tennagels, "On ceramides, other sphingolipids and impaired glucose homeostasis," Molecular Metabolism, vol. 3, no. 3, pp. 252-260, 2014.
43. S. Schiffmann, K. Birod, J. Mannich et al., "Ceramide metabolism in mouse tissue," International Journal of Biochemistry and Cell Biology, vol. 45, no. 8, pp. 1886-1894, 2013.
44. K. Konstantynowicz-Nowicka, E. Harasim, M. Baranowski, A. Chabowski, and A. Cowart, "New evidence for the role of ceramide in the development of hepatic insulin resistance," PLoS ONE, vol. 10, no. 1, Article IDe0116858, 2015.
45. M. J. Watt, A. C. Barnett, C. R. Bruce, S. Schenk, J. F. Horowitz, and A. J. Hoy, "Regulation of plasma ceramide levels with fatty acid oversupply: evidence that the liver detects and secretes de novo synthesised ceramide," Diabetologia, vol. 55, no. 10, pp. 2741-2746, 2012.
46. L. Leick, B. Lindegaard, D. Stensvold, P. Plomgaard, B. Saltin, and H. Pilegaard, "Adipose tissue interleukin-18 mRNA and plasma interleukin-18: effect of obesity and exercise," Obesity, vol. 15, no. 2, pp. 356-363, 2007.
47. M. G. Netea, L. A. B. Joosten, E. Lewis et al., "Deficiency of interleukin-18 in mice leads to hyperphagia, obesity and insulin resistance," Nature Medicine, vol. 12, no. 6, pp. 650-656, 2006.
48. B. Lindegaard, V. B. Matthews, C. Brandt et al., "Interleukin-18 activates skeletal muscle AMPK and reduces weight gain and insulin resistance in mice," Diabetes, vol. 62, no. 9, pp. 3064-3074, 2013.
49. V. A. Narkar, M. Downes, R. T. Yu et al., "AMPK and PPARδ agonists are exercise mimetics," Cell, vol. 134, no. 3, pp. 405-415, 2008.
50. K. T. Uysal, S. M. Wiesbrock, M. W. Marino, and G. S. Hotamisligil, "Protection from obesity-induced insulin resistance in mice lacking TNF-α function," Nature, vol. 389, no. 6651, pp. 610-614, 1997.